| 000 | 00909 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517224732.0 | ||
| 264 | 0 | _c20190812 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0000000000005725 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBradshaw, Michael J | |
| 245 | 0 | 0 |
_aAuthor response: Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. _h[electronic resource] |
| 260 |
_bNeurology _c07 2018 |
||
| 300 |
_a51-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aSarcoidosis |
| 700 | 1 | _aGelfand, Jeffrey M | |
| 700 | 1 | _aPawate, Siddharama | |
| 773 | 0 |
_tNeurology _gvol. 91 _gno. 1 _gp. 51-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0000000000005725 _zAvailable from publisher's website |
| 999 |
_c28593626 _d28593626 |
||